These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26870161)

  • 1. Use of genetically engineered stem cells for glioma therapy.
    Namba H; Kawaji H; Yamasaki T
    Oncol Lett; 2016 Jan; 11(1):9-15. PubMed ID: 26870161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
    Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in stem cell therapy against gliomas.
    Bovenberg MS; Degeling MH; Tannous BA
    Trends Mol Med; 2013 May; 19(5):281-91. PubMed ID: 23537753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell based glioblastoma gene therapy.
    Altaner C; Altanerova V
    Neoplasma; 2012; 59(6):756-60. PubMed ID: 22862177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal-Stem-Cell-Based Therapy against Gliomas.
    Santillán-Guaján SM; Shahi MH; Castresana JS
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
    Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
    Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.
    Friedman GK; Raborn J; Kelly VM; Cassady KA; Markert JM; Gillespie GY
    Front Oncol; 2013; 3():28. PubMed ID: 23450706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell therapies for malignant glioma.
    Ehtesham M; Stevenson CB; Thompson RC
    Neurosurg Focus; 2005 Sep; 19(3):E5. PubMed ID: 16190604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.
    Young JS; Morshed RA; Kim JW; Balyasnikova IV; Ahmed AU; Lesniak MS
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1733-46. PubMed ID: 25005767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma.
    Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T
    Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell-based therapy for malignant glioma.
    Bexell D; Svensson A; Bengzon J
    Cancer Treat Rev; 2013 Jun; 39(4):358-65. PubMed ID: 22795538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
    Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
    Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of neural stem cells as therapeutic vehicles for the treatment of malignant glioma.
    Ehtesham M; Kabos P; Black KL; Yu JS
    Expert Rev Neurother; 2003 Nov; 3(6):883-95. PubMed ID: 19810890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach?
    Tabatabai G; Wick W; Weller M
    Discov Med; 2011 Jun; 11(61):529-36. PubMed ID: 21712019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental therapies: gene therapies and oncolytic viruses.
    Hulou MM; Cho CF; Chiocca EA; Bjerkvig R
    Handb Clin Neurol; 2016; 134():183-97. PubMed ID: 26948355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
    Germano IM; Emdad L; Qadeer ZA; Binello E; Uzzaman M
    Cancer Gene Ther; 2010 Sep; 17(9):664-74. PubMed ID: 20523363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine does not affect stem cell properties requisite for suicide gene therapy against glioma.
    Kenmochi H; Yamasaki T; Koizumi S; Sameshima T; Namba H
    Neurol Res; 2020 Oct; 42(10):818-827. PubMed ID: 32588772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges.
    Benmelouka AY; Munir M; Sayed A; Attia MS; Ali MM; Negida A; Alghamdi BS; Kamal MA; Barreto GE; Ashraf GM; Meshref M; Bahbah EI
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.
    Auffinger B; Ahmed AU; Lesniak MS
    Front Oncol; 2013; 3():32. PubMed ID: 23443138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.